Moderna

MRNA(Moderna)

$58.10-0.17%

MRNA(Moderna) Price Prediction Summary

AI-Generated
As of July 22, 2026, MRNA is trading under increasing pressure across multiple dimensions. Technical deterioration \(MA20 sell, MACD bearish, price below short-term moving averages\) conflicts with institutional conviction \(78.8\% institutional holding\), while sentiment has turned sharply bearish \(IV rank 74, put/call 2.34, analyst target 30\% lower\). The stock faces a key structural test: institutional holders are defending their positions, but rising short interest and bearish option flow suggest professionals are positioning for further downside. The 50-day moving average around 57.61 is the nearest support; a close below that level would likely trigger cascade selling and validate the bearish sentiment. Uncertainty remains around near-term catalysts \(earnings, pipeline updates, sector rotation\) that could spark a reversal. Watch the 50-day MA break, IV rank compression, and short interest trend as critical variables.
Technical Indicators
Short-Term Bearish

Daily technicals lean bearish; MA20 sell signal and negative MACD diverge from longer-term uptrend; RSI neutral mid-range.

Market Sentiment
Bearish Sentiment

Market sentiment is decidedly bearish; IV rank elevated, put/call ratio high, and consensus price target 30% below current levels.

Market Structure
Institutional Holding Steady

Institutional ownership remains robust at 78.8%, but rising short interest (16.4%) suggests mounting bearish pressure from sophisticated traders.

Key Trading Levels

How Gate Predicts MRNA(Moderna) Price

Multi-Source Data Collection

Three independent data sources—technical indicators, market sentiment, and market structure signals—are integrated in real time, covering price behavior, trader behavior, and supply-demand dynamics, ensuring the analysis does not rely on a single dimension.

Independent Analysis by Dimension

Technical indicators are used to identify trends and structural positions, market sentiment is used to assess risk appetite, and market structure signals are used to identify supply-demand and positioning changes. Each dimension independently generates signals within its most appropriate time frame.

Cross-Validation of Composite Signals

When signals across multiple dimensions align, confidence in the assessment increases; when signals diverge, it indicates a transitional or consolidation phase, helping to avoid being misled by a single indicator.

Technical Indicators

AI-GeneratedAs of July 22, 2026, **MRNA technical analysis** reveals a short-term correction within a longer-term uptrend. The 20-day moving average sits at 68.27 with a sell signal, while the 50-day \(57.61\) and 200-day \(43.87\) averages remain in buy mode, indicating a bearish pullback from recent highs but support still elevated above the 200-day baseline. MACD at 0.626 is printing a sell signal, confirming weakness in near-term momentum. The RSI at 42.46 is neutral, neither overbought nor oversold, suggesting room to move lower before any capitulation signal emerges. The divergence between the MA20 sell and longer-moving-average buys signals a potential consolidation or retest of the 50-day level around 57.61. This MRNA price forecast hinges on whether the stock can hold above the 50-day or rolls further toward the 200-day support. Watch for a reversal confirmation if RSI dips below 30 or a MACD bullish cross; downside targets would be the 50-day moving average.
IndicatorValueSignal
Exponential Moving Average (10)63.6714
Sell
Exponential Moving Average (100)54.6267
Buy
Exponential Moving Average (20)64.4346
Sell
Exponential Moving Average (200)48.4157
Buy
Exponential Moving Average (30)63.0446
Sell
Exponential Moving Average (50)60.0747
Sell
Hull Moving Average (9)57.2494
Buy
Ichimoku Base Line (9, 26, 52, 26)67.7201
neutral
Moving Averages Summary
neutral
Simple Moving Average (10)64.975
Sell
Simple Moving Average (100)54.5991
Buy
Simple Moving Average (20)68.2275
Sell
Simple Moving Average (200)43.8695
Buy
Simple Moving Average (30)63.7152
Sell
Simple Moving Average (50)57.5995
Buy
Volume Weighted Moving Average (20)70.003
Sell
Average Directional Index (14)25.8047
neutral
Awesome Oscillator-0.5819
Sell
Bull Bear Power-11.2176
neutral
Commodity Channel Index (20)-111.9843
neutral
MACD Level (12, 26)0.5642
Sell
Momentum (10)-15.73
Buy
Oscillators Summary
neutral
Relative Strength Index (14)41.5149
neutral
Stochastic %K (14, 3, 3)1.9324
neutral
Stochastic RSI Fast (3, 3, 14, 14)0.2351
Buy
Ultimate Oscillator (7, 14, 28)38.1
neutral
Williams Percent Range (14)-98.8155
neutral
Technical Summary
neutral

Market Sentiment

AI-GeneratedAs of July 22, 2026, **MRNA market sentiment** reflects heavy bearish positioning. The IV rank at 74.17 out of 100 is in the upper tail, signaling elevated option volatility and hedging activity—a hallmark of fear in the market. The put/call ratio of 2.34 is significantly above unity, showing investors are buying puts at nearly 2.4 times the call volume, a classic defensive posture. Most tellingly, the consensus target price of 48.42 sits approximately 30\% below the current trading level \(inferred near 68+\), suggesting the Street collectively expects material downside. This MRNA price prediction is being dragged lower by analyst downgrades, likely driven by recent earnings misses, pipeline concerns, or competitive pressures in the mRNA space. The combination of high IV and skewed put/call demand indicates traders are paying up for downside protection, which often precedes accelerated selling. Keep watch on whether IV rank begins to compress as sentiment stabilizes, and monitor if the consensus target price is revised higher—such a move would signal healing sentiment.
Analyst Rating
49.3684
Options Put/Call Ratio
39.4600%
Implied Volatility (IV)
71.3266

Market Structure

AI-GeneratedAs of July 22, 2026, **MRNA market structure** shows a professional investor base in control but under siege. Institutional holding at 78.82\% is commanding and stable, indicating large asset managers and long-term holders have not capitulated. However, the short percent of float at 16.4\% is meaningful and trending higher, reflecting hedge funds and short-sellers building positions ahead of expected weakness. This divergence—heavy longs from institutions, growing shorts from tactical traders—points to a fractured market structure where retail and institutional buyers are being tested by professionally-executed downside bets. The floating share count of 370 million is moderate and stable, so there\'s no unusual dilution concern. The near-term battle is between institutional holders defending their position and shorts pressing for a break lower; a breakdown below the 50-day MA would likely trigger institutional stop-losses and accelerate short covering or further short accumulation. Watch the short interest trend—if it breaks above 18–20\% of float, capitulation fears could intensify.
Float Shares
370062704.0000
Short % of Float
0.1640
Institutional Holding
0.7883

Influencing Factors

Corporate Earnings and Profit Growth

Revenue, net profit, and forward guidance are the core factors affecting stock prices.

Industry Competition Landscape and Market Share

Changes in a company's competitiveness within the industry and its market share will impact its long-term valuation.

Overall Market Valuation and Interest Rate Environment

When interest rates rise or overall market valuations are elevated, individual stocks are more likely to experience pullbacks.

Institutional Funds and Market Sentiment

Large-scale institutional inflows or outflows, along with changes in market risk appetite, can amplify stock price volatility.

FAQ

What data is used to generate the MRNA(Moderna) price prediction?

x

MRNA(Moderna) price prediction is typically based on three types of data: technical indicators (e.g., RSI, MACD, moving averages), market sentiment (e.g., capital flows and derivatives data), and market structure signals (e.g., positioning and supply-demand changes). Multi-dimensional data is used to enhance the completeness of the analysis.

How do supply and demand affect the MRNA(Moderna) price prediction?

x

How are technical indicators used in the MRNA(Moderna) price prediction?

x

What role does market sentiment play in the MRNA(Moderna) price prediction?

x

What common factors can influence the MRNA(Moderna) price prediction?

x

How can price predictions be used to assess the current market state of MRNA(Moderna)?

x

Disclaimer

Gate only provides trade execution services. Any information, reports, opinions, comments, or other materials obtained from Gate, its employees, Gate-provided analytical tools, or third-party research do not constitute investment advice and should not be relied upon for investment decisions. You agree to do your own research and verify external information sources before making any investment. You further agree that Gate shall not be held liable for any loss or damage (including but not limited to loss of profits) arising directly or indirectly from the use of or reliance on such information. Nothing contained in any reports shall be interpreted as an explicit or implied promise, guarantee, or indication of profit, nor does it guarantee that losses can be limited or avoided. Please also note that data related to traditional finance such as forex and CFDs (e.g., real-time prices) displayed on this page is sourced from third parties, is provided for reference only, and is offered on an "as-is" basis without any representations or warranties of any kind, express or implied. Any third-party website links provided are not under Gate's control. Gate assumes no responsibility for the reliability or accuracy of such third-party websites or their content. For further details, please refer to our User Agreement.

Risk Warning

Traditional finance such as forex and CFDs may experience significant price fluctuations. Past performance is not a reliable indicator of future results. The vast majority of retail client accounts incur losses when trading forex and CFDs. Please ensure you fully understand how forex and CFDs operate and assess whether you are able to bear the risk of substantial losses. Even with stop-loss orders, your losses may exceed your initial deposit. Therefore, you should not engage in speculative trading with funds you cannot afford to lose, and you should ensure you are fully aware of the risks involved. The information provided by Gate is general in nature and does not take into account your investment objectives, financial situation, or specific needs. The content and prices on this website must not be interpreted as personal investment advice. Please ensure you fully understand the risks involved and seek independent professional advice where necessary. Gate reserves the right to terminate services at its sole discretion at any time. Gate is not liable for any losses resulting from such termination, including losses caused by closing positions at unfavorable market prices or forced liquidation. For more information, please refer to our Risk Disclosure.